Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1990 2
1994 1
1995 1
1996 1
1998 2
1999 2
2000 1
2001 1
2002 3
2003 4
2005 4
2006 2
2007 1
2008 2
2009 3
2010 1
2011 2
2012 2
2013 1
2016 2
2017 7
2018 10
2019 5
2020 7
2021 12
2022 13
2023 9
2024 12
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis.
Portaccio E, Fonderico M, Iaffaldano P, Pastò L, Razzolini L, Bellinvia A, De Luca G, Ragonese P, Patti F, Brescia Morra V, Cocco E, Sola P, Inglese M, Lus G, Pozzilli C, Maimone D, Lugaresi A, Gazzola P, Comi G, Pesci I, Spitaleri D, Rezzonico M, Vianello M, Avolio C, Logullo FO, Granella F, Salvetti M, Zaffaroni M, Lucisano G, Filippi M, Trojano M, Amato MP; Italian Multiple Sclerosis Register Centers Group. Portaccio E, et al. Among authors: avolio c. JAMA Neurol. 2022 Sep 1;79(9):869-878. doi: 10.1001/jamaneurol.2022.1929. JAMA Neurol. 2022. PMID: 35877104 Free PMC article. Clinical Trial.
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study.
Zanghì A, Borriello G, Bonavita S, Fantozzi R, Signoriello E, Barone S, Abbadessa G, Cellerino M, Ziccone V, Miele G, Lus G, Valentino P, Bucello S, Inglese M, Centonze D, Avolio C, D'Amico E. Zanghì A, et al. Among authors: avolio c. J Neurol. 2024 Jul;271(7):4495-4502. doi: 10.1007/s00415-024-12360-x. Epub 2024 May 4. J Neurol. 2024. PMID: 38704488 Free PMC article.
Myeloid-derived Suppressor Cells and Multiple Sclerosis.
Zanghì A, Filippo PSD, Avolio C, D'Amico E. Zanghì A, et al. Among authors: avolio c. Curr Neuropharmacol. 2024;23(1):36-57. doi: 10.2174/1570159X22999240710142942. Curr Neuropharmacol. 2024. PMID: 38988152 Free PMC article. Review.
Multiple Sclerosis Progression and Relapse Activity in Children.
Iaffaldano P, Portaccio E, Lucisano G, Simone M, Manni A, Guerra T, Paolicelli D, Betti M, De Meo E, Pastò L, Razzolini L, Rocca MA, Ferrè L, Brescia Morra V, Patti F, Zaffaroni M, Gasperini C, De Luca G, Ferraro D, Granella F, Pozzilli C, Romano S, Gallo P, Bergamaschi R, Coniglio MG, Lus G, Vianello M, Banfi P, Lugaresi A, Totaro R, Spitaleri D, Cocco E, Di Palma F, Maimone D, Valentino P, Torri Clerici V, Protti A, Maniscalco GT, Salemi G, Pesci I, Aguglia U, Lepore V, Filippi M, Trojano M, Amato MP; Italian Multiple Sclerosis Register. Iaffaldano P, et al. JAMA Neurol. 2024 Jan 1;81(1):50-58. doi: 10.1001/jamaneurol.2023.4455. JAMA Neurol. 2024. PMID: 38010712 Free PMC article.
Multiple sclerosis from onset to secondary progression: a 30-year Italian register study.
Zanghì A, Copetti M, Avolio C, Paolicelli D, Romeo MAL, Patti F, De Luca G, Amato MP, Galgani S, Sola P, Salemi G, Gallo P, Granella F, Romano S, Zaffaroni M, Bergamaschi R, Pozzilli C, Lus G, Vianello M, Trojano M, D'Amico E; Italian Multiple Sclerosis register. Zanghì A, et al. Among authors: avolio c. J Neurol Neurosurg Psychiatry. 2025 Oct 15;96(11):1061-1069. doi: 10.1136/jnnp-2025-335958. J Neurol Neurosurg Psychiatry. 2025. PMID: 40518265 Free PMC article.
Brivaracetam in absence status epilepticus.
d'Orsi G, Lalla A, Di Claudio MT, Valenzano A, Sabetta A, Avolio C. d'Orsi G, et al. Among authors: avolio c. Seizure. 2020 Aug;80:3-4. doi: 10.1016/j.seizure.2020.05.015. Epub 2020 May 24. Seizure. 2020. PMID: 32480279 Free article. No abstract available.
Early Intensive Versus Escalation Approach: Ten-Year Impact on Disability in Relapsing Multiple Sclerosis.
Iaffaldano P, Lucisano G, Guerra T, Caputo F, Simone M, Copetti M, Paolicelli D, Portaccio E, Patti F, Perini P, Brescia Morra V, Di Sapio A, Inglese M, Pozzilli C, Lus G, Salemi G, Curti E, De Luca G, Valentino P, Cocco E, Cavalla P, Avolio C, Lugaresi A, Gallo A, Annovazzi P, Rocca MA, Chisari CG, Filippi M, Amato MP, Trojano M; Italian MS Register. Iaffaldano P, et al. Among authors: avolio c. Ann Clin Transl Neurol. 2025 Oct;12(10):2012-2019. doi: 10.1002/acn3.70131. Epub 2025 Jul 6. Ann Clin Transl Neurol. 2025. PMID: 40619726 Free PMC article.
119 results